|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics. CA Cancer J Clin.
58:71–96. 2008.
|
|
2
|
Horner MJ, Ries LAG, Krapcho M, et al:
SEER cancer statistics review, 1975–2006. Bethesda, MD: National
Cancer Institute. http://seercancergov/csr/1975-2006/.
2009
|
|
3
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 1:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sjöblom T, Jones S, Wood LD, et al: The
consensus coding sequences of human breast and colorectal cancers.
Science. 13:268–274. 2006.
|
|
5
|
Bretscher A, Chambers D, Nguyen R and
Reczek D: ERM-Merlin and EBP50 protein families in plasma membrane
organization and function. Annu Rev Cell Dev Biol. 16:113–143.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Voltz JW, Weinman EJ and Shenolikar S:
Expanding the role of NHERF, a PDZ-domain containing protein
adapter, to growth regulation. Oncogene. 20:6309–6314. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mahon MJ, Donowitz M, Yun CC and Segre GV:
Na(+)/H(+) exchanger regulatory factor 2 directs parathyroid
hormone 1 receptor signalling. Nature. 20:858–861. 2002.
|
|
8
|
Shenolikar S, Voltz JW, Cunningham R and
Weinman EJ: Regulation of ion transport by the NHERF family of PDZ
proteins. Physiology. 19:362–369. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weinman EJ, Hall RA, Friedman PA, Liu-Chen
LY and Shenolikar S: The association of NHERF adaptor proteins with
g protein-coupled receptors and receptor tyrosine kinases. Annu Rev
Physiol. 68:491–505. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mangia A, Chiriatti A, Bellizzi A,
Malfettone A, Stea B, Zito FA, Reshkin SJ, Simone G and Paradiso A:
Biological role of NHERF1 protein expression in breast cancer.
Histopathology. 55:600–608. 2009. View Article : Google Scholar
|
|
11
|
Curto M, Cole BK, Lallemand D, Liu CH and
McClatchey AI: Contact-dependent inhibition of EGFR signaling by
Nf2/Merlin. J Cell Biol. 5:893–903. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fanning AS and Anderson JM: PDZ domains:
fundamental building blocks in the organization of protein
complexes at the plasma membrane. J Clin Invest. 103:767–772. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reczek D, Berryman M and Bretscher A:
Identification of EBP50: A PDZ-containing phosphoprotein that
associates with members of the ezrin-radixin-moesin family. J Cell
Biol. 6:169–179. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Louvet-Vallée S: ERM proteins: from
cellular architecture to cell signalling. Biol Cell. 92:305–316.
2000.PubMed/NCBI
|
|
15
|
Mahon MJ and Segre GV: Stimulation by
parathyroid hormone of a NHERF-1-assembled complex consisting of
the parathyroid hormone I receptor, phospholipase Cbeta, and actin
increases intracellular calcium in opossum kidney cells. J Biol
Chem. 28:23550–23558. 2004. View Article : Google Scholar
|
|
16
|
Fouassier L, Duan CY, Feranchak AP, et al:
Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the
apical membrane of rat liver epithelia. Hepatology. 33:166–176.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Donowitz M, Cha B, Zachos NC, Brett CL,
Sharma A, Tse CM and Li X: NHERF family and NHE3 regulation. J
Physiol. 567:3–11. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pan Y, Wang L and Dai JL: Suppression of
breast cancer cell growth by Na+/H+ exchanger
regulatory factor 1 (NHERF1). Breast Cancer Res. 8:R632006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shibata T, Chuma M, Kokubu A, Sakamoto M
and Hirohashi S: EBP50, a beta-catenin associating protein,
enhances Wnt signaling and is overexpressed in hepatocellular
carcinoma. Hepatology. 38:178–186. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fraenzer JT, Pan H, Minimo L Jr, Smith GM,
Knauer D and Hung G: Overexpression of the NF2 gene inhibits
schwannoma cell proliferation through promoting PDGFR degradation.
Int J Oncol. 24:1493–1500. 2003.PubMed/NCBI
|
|
21
|
Stemmer-Rachamimov AO, Wiederhold T,
Nielsen GP, et al: NHE-RF, a merlin-interacting protein, is
primarily expressed in luminal epithelia, proliferative
endometrium, and estrogen receptor-positive breast carcinomas. Am J
Pathol. 158:57–62. 2001. View Article : Google Scholar
|
|
22
|
Song J, Bai J, Yang W, Gabrielson EW, Chan
DW and Zhang Z: Expression and clinicopathological significance of
oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50
in breast cancer. Histopathology. 51:40–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Georgescu MM, Morales FC, Molina JR and
Hayashi Y: Roles of NHERF1/EBP50 in cancer. Curr Mol Med.
8:459–468. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cardone RA, Bagorda A, Bellizzi A, Busco
G, Guerra L, Paradiso A, Casavola V, Zaccolo M and Reshkin SJ:
Protein kinase A gating of a pseudopodial-located
RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast
cancer cell lines. Mol Biol Cell. 16:3117–3127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cardone RA, Bellizzi A, Busco G, Weinman
EJ, Dell’Aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A
and Reshkin SJ: The NHERF1 PDZ2 domain regulates
PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor
cells. Mol Biol Cell. 18:1768–1480. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hayashi Y, Molina JR, Hamilton SR and
Georgescu MM: NHERF1/EBP50 is a new marker in colorectal cancer.
Neoplasia. 12:1013–1022. 2010.PubMed/NCBI
|
|
27
|
Hamilton SR, Vogelstein B, Kudo S, Riboli
E, Nakamura S and Hainaut P: Carcinoma of the colon and rectum. WHO
Classification of Tumors: Pathology and Genetics of Tumors of
Digestive System. Hamilton SR and Aaltonen LA: IARC Press; Lyon,
France: pp. 105–119. 2000
|
|
28
|
Goldstein NS and Armin M: Epidermal growth
factor receptor immunohistochemical reactivity in patients with
American Joint Committee on Cancer Stage IV colon adenocarcinoma:
implications for a standardized scoring system. Cancer.
92:1331–1346. 2001. View Article : Google Scholar
|
|
29
|
Takahashi Y, Morales FC, Kreimann EL and
Georgescu MM: PTEN tumor suppressor associates with NHERF proteins
to attenuate PDGF receptor signalling. EMBO J. 5:910–920. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kreimann EL, Morales FC, de Orbeta-Cruz J,
Takahashi Y, Adams H, Liu TJ, McCrea PD and Georgescu MM: Cortical
stabilization of beta-catenin contributes to NHERF1/EBP50 tumor
suppressor function. Oncogene. 26:5290–5299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lazar CS, Cresson CM, Lauffenburger DA and
Gill GN: The Na+/H+ exchanger regulatory
factor stabilizes epidermal growth factor receptors at the cell
surface. Mol Biol Cell. 15:5470–5480. 2004.
|
|
32
|
Wei Q, Shui Y, Zheng S, Wester K, Nordgren
H, Nygren P, Glimelius B and Carlsson J: EGFR, HER2 and HER3
expression in primary colorectal carcinomas and corresponding
metastases: implications for targeted radionuclide therapy. Oncol
Rep. 25:3–11. 2011.PubMed/NCBI
|
|
33
|
Ljuslinder I, Malmer B,
Isaksson-Mettävainio M, Oberg A, Henriksson R, Stenling R and
Palmqvist R: ErbB 1–4 expression alterations in primary colorectal
cancers and their corresponding metastases. Anticancer Res.
29:1489–1494. 2009.
|
|
34
|
Scartozzi M, Bearzi I, Berardi R,
Mandolesi A, Pierantoni C and Cascinu S: Epidermal growth factor
receptor (EGFR) downstream signalling pathway in primary colorectal
tumours and related metastatic sites: optimising EGFR-targeted
treatment options. Br J Cancer. 97:92–97. 2007. View Article : Google Scholar
|
|
35
|
Krasinskas AM: EGFR signaling in
colorectal carcinoma. Patholog Res Int. 9329322011.PubMed/NCBI
|
